# Bank of Nova Scotia: financial statements, quarterly

BNS · NYSE · CIK 9631 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/bns.md) · [Financials](/companies/bns/financials.md) · [Filings](/companies/bns/filings.md) · [Insiders](/companies/bns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bns/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-10-31) | period not labelled (2016-10-31) | period not labelled (2017-10-31) | FY2018 (2018-10-31) | FY2019 (2019-10-31) | FY2020 (2020-10-31) | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [6.7](/filings/0001193125-18-335067.md) | [6.9](/filings/0001193125-19-301103.md) | [7.8](/filings/0001193125-20-306924.md) | [9.0](/filings/0001193125-21-343582.md) | [10.9](/filings/0001193125-21-343582.md) | [11.1](/filings/0001193125-22-294230.md) | [9.7](/filings/0001193125-23-284197.md) | [11.1](/filings/0001193125-24-269887.md) | [10.2](/filings/0001193125-25-304643.md) | [9.4](/filings/0001193125-25-304643.md) | [10.3](/filings/0001193125-25-304643.md) |
| Total assets | $bn | not reported | not reported | [915](/filings/0001193125-18-335067.md) | [998](/filings/0001193125-19-301103.md) | [1,086](/filings/0001193125-20-306924.md) | [1,136](/filings/0001193125-21-343582.md) | [1,185](/filings/0001193125-22-294230.md) | [1,349](/filings/0001193125-23-284197.md) | [1,411](/filings/0001193125-24-269887.md) | [1,412](/filings/0001193125-25-304643.md) | [1,460](/filings/0001193125-25-304643.md) |
| Total liabilities | $bn | not reported | not reported | [854](/filings/0001193125-18-335067.md) | [931](/filings/0001193125-19-301103.md) | [1,016](/filings/0001193125-20-306924.md) | [1,066](/filings/0001193125-21-343582.md) | [1,112](/filings/0001193125-22-294230.md) | [1,275](/filings/0001193125-23-284197.md) | [1,332](/filings/0001193125-24-269887.md) | [1,328](/filings/0001193125-25-304643.md) | [1,371](/filings/0001193125-25-304643.md) |
| Shareholders' equity | $bn | [53.5](/filings/0001193125-18-335067.md) | [57.8](/filings/0001193125-19-301103.md) | [60.0](/filings/0001193125-18-335067.md) | [65.2](/filings/0001193125-19-301103.md) | [67.5](/filings/0001193125-20-306924.md) | [68.1](/filings/0001193125-21-343582.md) | [70.8](/filings/0001193125-22-294230.md) | [73.2](/filings/0001193125-23-284197.md) | [76.8](/filings/0001193125-24-269887.md) | [82.4](/filings/0001193125-25-304643.md) | [86.9](/filings/0001193125-25-304643.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,236,305,738 at 2025-10-31, from the cover of the [40-F filed 2025-12-02](/filings/0001193125-25-304643.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.